[{"Assets_0_Q1_USD":13218650000.0,"CommonStockSharesConverted_0_Q1_shares":223103675.0,"CommonStockSharesOutstanding_0_Q1_shares":223103675.0,"EarningsPerShareBasic_1_Q1_USD":-0.78,"EarningsPerShareDiluted_1_Q1_USD":-0.78,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":167763000.0,"NetIncomeLossConverted_1_Q1_USD":-173828000.0,"RevenuesConverted_1_Q1_USD":1037600000.0,"StockholdersEquityConverted_0_Q1_USD":2188053000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":223014000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":223014000.0,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170509"}]